Experimental models of multiple sclerosis

被引:63
作者
Pachner, Andrew R. [1 ]
机构
[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ 07103 USA
关键词
animal models; autoimmunity; demyelination; multiple sclerosis; virus; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; THEILERS-VIRUS-INFECTION; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; B-CELL DEPLETION; DEMYELINATING DISEASE; NEUROMYELITIS-OPTICA; VIRAL REPLICATION; IMMUNE-RESPONSES;
D O I
10.1097/WCO.0b013e328346c226
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose of review Multiple sclerosis (MS) is a disease of the central nervous system of unknown cause. There are many medications available for the disease, but none are clearly effective in ameliorating its long-term disabling effects. MS is felt to be most likely either due to an aberrant immune response or a pathogen, or possibly a combination of the two, and the animal models available reflect these two possible pathogeneses. The hallmarks of the disease are demyelination, inflammation, axonal injury, and progressive disability. This review explores the experimental models of multiple sclerosis. Recent findings There are a variety of forms of experimental allergic encephalomyelitis, the most commonly studied animal model of MS. Two viruses, Theiler's murine encephalomyelitis virus and murine hepatitis virus, are used to induce infectious models of the disease. Summary The animal models have their advantages and disadvantages, but no model fully reproduces the spectrum of the human disease.
引用
收藏
页码:291 / 299
页数:9
相关论文
共 62 条
[1]   TNF neutralization in MS - Results of a randomized, placebo-controlled multicenter study [J].
Arnason, BGW ;
Jacobs, G ;
Hanlon, M ;
Clay, BH ;
Noronha, ABC ;
Auty, A ;
Davis, B ;
Nath, A ;
Bouchard, JP ;
Belanger, C ;
Gosselin, F ;
Thibault, M ;
Duquette, P ;
Bourgoin, P ;
DuBois, R ;
Girard, M ;
Ebers, GC ;
Rice, GPA ;
Vandervoort, MK ;
Francis, GS ;
Duncan, L ;
Lapierre, Y ;
Freedman, MS ;
Christie, SN ;
Rabinovitch, HE ;
Patry, D ;
Murphy, WF ;
Peters, S ;
McGuiness, SD ;
Murray, TJ ;
Bhan, V ;
Maxner, CE ;
Van Dorpe, R ;
Oger, JJ ;
Nelson, J ;
Morrison, W ;
Bogle, N ;
Beall, S ;
Vorobeychick, G ;
Hiltbrunner, AV ;
Bock, J ;
Habil ;
Lesslauer, W ;
Li, DKB ;
Paty, DW ;
Zhao, GJ .
NEUROLOGY, 1999, 53 (03) :457-465
[2]   Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial [J].
Bar-Or, Amit ;
Calabresi, Peter A. J. ;
Arnlod, Douglas ;
Markowitz, Clyde ;
Shafer, Stuart ;
Kasper, Lloyd H. ;
Waubant, Ernmanuelle ;
Gazda, Suzanne ;
Fox, Robert J. ;
Panzara, Michael ;
Sarkar, Neena ;
Agarwal, Sunil ;
Smith, Craig H. .
ANNALS OF NEUROLOGY, 2008, 63 (03) :395-400
[3]   Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion [J].
Barnett, MH ;
Prineas, JW .
ANNALS OF NEUROLOGY, 2004, 55 (04) :458-468
[4]   Intrathecal Pathogenic Anti-Aquaporin-4 Antibodies in Early Neuromyelitis Optica [J].
Bennett, Jeffrey L. ;
Lam, Chiwah ;
Kalluri, Sudhakar Reddy ;
Saikali, Philippe ;
Bautista, Katherine ;
Dupree, Cecily ;
Glogowska, Magdalena ;
Case, David ;
Antel, Jack P. ;
Owens, Gregory P. ;
Gilden, Don ;
Nessler, Stefan ;
Stadelmann, Christine ;
Hemmer, Bernhard .
ANNALS OF NEUROLOGY, 2009, 66 (05) :617-629
[5]   THE RAPID ISOLATION OF CLONABLE ANTIGEN-SPECIFIC LYMPHOCYTE-T LINES CAPABLE OF MEDIATING AUTOIMMUNE ENCEPHALOMYELITIS [J].
BENNUN, A ;
WEKERLE, H ;
COHEN, IR .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (03) :195-199
[6]  
Blakemore WF, 2008, CURR TOP MICROBIOL, V318, P193
[7]   Neuromyelitis Optica: Pathogenicity of Patient Immunoglobulin In Vivo [J].
Bradl, Monika ;
Misu, Tatsuro ;
Takahashi, Toshiyuki ;
Watanabe, Mitsutoshi ;
Mader, Simone ;
Reindl, Markus ;
Adzemovic, Milena ;
Bauer, Jan ;
Berger, Thomas ;
Fujhara, Kazuo ;
Itoyama, Yasuto ;
Lassmann, Hans .
ANNALS OF NEUROLOGY, 2009, 66 (05) :630-643
[8]   Permeabilization in a cerebral endothelial barrier model by pertussis toxin involves the PKC effector pathway and is abolished by elevated levels of cAMP [J].
Brückener, KE ;
el Bayâ, A ;
Galla, HJ ;
Schmidt, MA .
JOURNAL OF CELL SCIENCE, 2003, 116 (09) :1837-1846
[9]   ANTIADHESION MOLECULE THERAPY IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS [J].
CANNELLA, B ;
CROSS, AH ;
RAINE, CS .
JOURNAL OF NEUROIMMUNOLOGY, 1993, 46 (1-2) :43-56
[10]   Cytokine networks in multiple sclerosis: lost in translation [J].
Codarri, Laura ;
Fontana, Adriano ;
Becher, Burkhard .
CURRENT OPINION IN NEUROLOGY, 2010, 23 (03) :205-211